Novo, Anthropic Team Up to Advance Drug Discovery via AI

MT Newswires · 3d ago
09:14 AM EDT, 09/16/2026 (MT Newswires) -- Novo (NOVO-B.CO) is collaborating with artificial intelligence company Anthropic to advance the development of new medicines through Claude Science, according to a Wednesday release. The collaboration aims to address key drug discovery challenges identified by Novo's scientists and computational teams. As an initial goal, the Danish drugmaker will test Anthropic's Claude Science on specific research and development workflows and target scientific problems where the companies' joint capabilities will have the "greatest impact." Novo will also tap into Anthropic's frontier models to bolster AI-driven software development across the company.